Revolution Medicines and Iambic Announce Technology and Research Collaboration
Read more
Platform
Pipeline
Partnerships
News & Media
About
Careers
Contact
Contact
Press
Back to News and Media
Entos (now Iambic) Included in Business Insider's List of Most-Promising Healthcare Start-Ups of 2023
Press
This is some text inside of a div block.
July 19, 2023
Media Contacts
Related announcements
View All
View All
August 5, 2025
Former Amgen SVP of Global Research and Renowned Cell Biologist Ray Deshaies Named to Iambic’s Scientific Advisory Board
Read more
August 5, 2025
Former Amgen SVP of Global Research and Renowned Cell Biologist Ray Deshaies Named to Iambic’s Scientific Advisory Board
Read more
July 9, 2025
Revolution Medicines and Iambic Announce Technology and Research Collaboration Using Iambic’s AI Discovery Tools to Pursue New Drug Candidates
Read more
July 9, 2025
Revolution Medicines and Iambic Announce Technology and Research Collaboration Using Iambic’s AI Discovery Tools to Pursue New Drug Candidates
Read more
June 26, 2025
Iambic takes the lead for Next-Gen AI Drug Discovery with Lambda
Read more
June 26, 2025
Iambic takes the lead for Next-Gen AI Drug Discovery with Lambda
Read more